NCT05451849 2025-08-27A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing CancerTCR2 TherapeuticsPhase 1/2 Active not recruiting6 enrolled
NCT00002475 2013-07-10Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced CancerNational Cancer Institute (NCI)Phase 2 Completed40 enrolled